Knight Therapeutics Inc logo

Knight Therapeutics Inc

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada and internationally. It offers Impavido (miltefosine), an oral antifungal product for the treatment of visceral, cutaneous, and mucosal leishmaniasis; Macrilen (macimorelin), a growth hormone secretagogue receptor agonist for use in the investigational stimulation testing of adults with adult growth hormone deficiency; Probuphine (buprenorphine) implant for subdermal administration to facilitate remission from opioid use disorder; Neuragen or NeurogesX topical research portfolio consisting of Qutenza (capsaicin 8% patch) for neuropathic pain indication in Canada.

Latest events on Quartr

Previous Events for Knight Therapeutics Inc

Ticker

GUD

Country

United States of America

About the company

https://www.gud-knight.com/overview/

Investor Relations page

https://www.gud-knight.com/investors-overview/

Dig deeper into the fundamentals using Quartr - Investor relations

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
Android play link
App store link
Quartr app screenshot